Literature DB >> 8659126

Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins.

E Kretzschmar1, M Bui, J K Rose.   

Abstract

The matrix protein of influenza virus is a major structural component of the virion which is generally believed to bridge between the membrane envelope and the ribonucleocapsid core. To investigate the interaction of M1 with cellular membranes in the absence of other influenza proteins, we examined its distribution by subcellular fractionation after expression in HeLa cells. Approximately 81 to 88% of M1 protein, expressed without other viral proteins, was soluble, whereas the remaining 12 to 19% was tightly associated with membranes. Conditions known to release peripherally associated membrane proteins did not detach M1 proteins from isolated membranes, suggesting that the fraction of M1 bound to membranes behaves as an integral protein. Coexpression of M1 with hemagglutinin or neuraminidase did not alter the extent of membrane association of M1 protein, indicating that there is no strong interaction between M1 and the cytoplasmic tails of the viral glycoproteins. Additional attempts were made to identify membrane binding domains in M1 protein. Mutants constructed with mutations in the four hydrophobic regions thought to be responsible for membrane association still exhibited the same levels of membrane association as that observed with wild-type matrix protein. Therefore, specific hydrophobic domains are apparently not required for membrane binding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8659126     DOI: 10.1006/viro.1996.0283

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

Authors:  M Bui; E G Wills; A Helenius; G R Whittaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Influenza virus matrix protein is the major driving force in virus budding.

Authors:  P Gómez-Puertas; C Albo; E Pérez-Pastrana; A Vivo; A Portela
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

Authors:  E Kretzschmar; L Buonocore; M J Schnell; J K Rose
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

5.  The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells.

Authors:  Svetlana V Bourmakina; Adolfo García-Sastre
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected].

Authors:  Thomas Strecker; Robert Eichler; Jan ter Meulen; Winfried Weissenhorn; Hans Dieter Klenk; Wolfgang Garten; Oliver Lenz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 7.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

8.  RAB11A is essential for transport of the influenza virus genome to the plasma membrane.

Authors:  Amie J Eisfeld; Eiryo Kawakami; Tokiko Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

9.  The functions of the actin nucleator Cobl in cellular morphogenesis critically depend on syndapin I.

Authors:  Lukas Schwintzer; Nicole Koch; Rashmi Ahuja; Julia Grimm; Michael M Kessels; Britta Qualmann
Journal:  EMBO J       Date:  2011-07-01       Impact factor: 11.598

10.  Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus.

Authors:  Masaki Imai; Kazunori Kawasaki; Takato Odagiri
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.